In Vivo Screening Data Summary

NCI In Vivo Screening Data

P1798 Lymphosarcoma (subcutaneous) in CD2F1 (CDF1) mice

NSC 3088
CAS 305-03-3
Chlorambucil; Leukeran; Ambochlorin

Chemical Data
Schedule (route) Endpoint Vehicle Dose Treated/Control (%) Observations
Q01DX010 (ip) mean tumor weight saline 1.56 mg/kg/injection 69.0 Antitumor endpoint evaluated on day 12; 06/06 animals surviving on tox evaluation day (usually day 5)
Q01DX010 (ip) mean tumor weight saline 3.13 mg/kg/injection 52.0 Antitumor endpoint evaluated on day 12; 06/06 animals surviving on tox evaluation day (usually day 5)
Q01DX010 (ip) mean tumor weight saline 3.13 mg/kg/injection 31.0 Antitumor endpoint evaluated on day 12; 06/06 animals surviving on tox evaluation day (usually day 5)
Q01DX010 (ip) mean tumor weight saline 6.25 mg/kg/injection 32.0 Antitumor endpoint evaluated on day 12; 06/06 animals surviving on tox evaluation day (usually day 5)
Q01DX010 (ip) mean tumor weight saline 6.25 mg/kg/injection 37.0 Antitumor endpoint evaluated on day 12; 05/06 animals surviving on tox evaluation day (usually day 5)
Q01DX010 (ip) mean tumor weight saline 12.5 mg/kg/injection 0.0 Antitumor endpoint evaluated on day 12; 01/06 animals surviving on tox evaluation day (usually day 5)
Q01DX010 (ip) mean tumor weight saline 12.5 mg/kg/injection 3.0 Antitumor endpoint evaluated on day 12; 05/06 animals surviving on tox evaluation day (usually day 5)
Q01DX010 (ip) mean tumor weight saline 25.0 mg/kg/injection 0.0 Antitumor endpoint evaluated on day 12; 00/06 animals surviving on tox evaluation day (usually day 5)